Literature DB >> 2758229

Effect of pirenzepine and gallamine on cardiac and pulmonary muscarinic receptors in the rabbit.

J Maclagan1, D Faulkner.   

Abstract

1. The effect of muscarinic antagonists considered to be selective for M1 receptors (pirenzepine) and for M2 receptors (gallamine) were studied on bronchoconstriction and bradycardia elicited by stimulation of the vagal nerves and by i.v. acetylcholine (ACh) in anaesthetized rabbits. 2. Pirenzepine was equipotent as an antagonist of ACh-induced responses at postjunctional muscarinic receptors in the heart, lung and blood vessels, whereas gallamine was at least ten times less potent at pulmonary and vascular muscarinic receptors. Thus, gallamine never caused complete inhibition of bronchoconstrictor or hypotensive responses to i.v. ACh, whereas doses of pirenzepine in excess of 1 mumol kg-1 abolished all muscarinic responses. 3. In the lung, both antagonists inhibited bronchoconstriction caused by vagal stimulation and ACh-induced bronchoconstriction to the same extent (pirenzepine, mean ED50 65 +/- 22 and, 130 +/- 28 nmol kg-1 respectively; gallamine, ED50 greater than 10,000 nmol kg-1 for both responses). Enhancement of vagally-induced bronchoconstriction was never observed. 4. In the heart, however, both pirenzepine and gallamine were ten times less potent as antagonists of vagally-induced bradycardia than of ACh-induced bradycardia. This differential blockade was unaltered by propranolol (1 mg kg-1) pretreatment. 5. It is concluded that there is no evidence for M1 or M2 muscarinic receptors in the pulmonary innervation of the rabbit and the potency of the antagonists in abolishing in abolishing vagally-induced bronchoconstriction was consistent with blockade of M3 muscarinic receptors on airway smooth muscle. 6. The results suggest that M2 muscarinic receptors may exert an inhibitory effect on transmission in the parasympathetic nerves innervating the heart in the rabbit. Blockade of such neuronal receptors would increase transmitter output to the atrial cells and explain the low potency of both antagonists in abolishing vagally-induced bradycardia in the rabbit.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2758229      PMCID: PMC1854516          DOI: 10.1111/j.1476-5381.1989.tb11979.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  The innervation of mammalian bronchial smooth muscle: the localization of catecholamines and cholinesterases.

Authors:  S P Mann
Journal:  Histochem J       Date:  1971-09

Review 2.  Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature.

Authors:  R M Eglen; R L Whiting
Journal:  J Auton Pharmacol       Date:  1986-12

3.  Subtypes of muscarinic receptor on cholinergic nerves and atrial cells of chicken and guinea-pig hearts.

Authors:  D Jeck; R Lindmar; K Löffelholz; M Wanke
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

4.  Autoregulation of acetylcholine release from vagus nerve terminals through activation of muscarinic receptors in the dog trachea.

Authors:  Y Ito; T Yoshitomi
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

5.  Identification of M1 muscarinic receptors in pulmonary sympathetic nerves in the guinea-pig by use of pirenzepine.

Authors:  J Maclagan; A D Fryer; D Faulkner
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

6.  A muscarinic receptor with high affinity for pirenzepine mediates vagally induced bronchoconstriction.

Authors:  J W Bloom; H I Yamamura; C Baumgartener; M Halonen
Journal:  Eur J Pharmacol       Date:  1987-01-06       Impact factor: 4.432

7.  Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons.

Authors:  G T Wetzel; J H Brown
Journal:  Am J Physiol       Date:  1985-01

8.  Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle.

Authors:  L C Blaber; A D Fryer; J Maclagan
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

9.  Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig.

Authors:  A D Fryer; J Maclagan
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

  9 in total
  9 in total

1.  Sequence dependence of post-tetanic potentiation after sequential heterosynaptic stimulation in the rat auditory cortex.

Authors:  K Seki; M Kudoh; K Shibuki
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

2.  Different muscarinic receptors mediate autoinhibition of acetylcholine release and vagally-induced vasoconstriction in the rat isolated perfused heart.

Authors:  I T Bognar; B Beinhauer; P Kann; H Fuder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

3.  Conditional involvement of muscarinic M1 receptors in vagally mediated contraction of guinea-pig bronchi.

Authors:  R E ten Berge; A F Roffel; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

4.  Functional characterization of muscarinic receptors in murine airways.

Authors:  J Garssen; H Van Loveren; C M Gierveld; H Van der Vliet; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

5.  Identification of M1 muscarinic receptors in pulmonary sympathetic nerves in the guinea-pig by use of pirenzepine.

Authors:  J Maclagan; A D Fryer; D Faulkner
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

6.  Release of [3H]acetylcholine from the isolated rat or guinea-pig trachea evoked by preganglionic nerve stimulation; a comparison with transmural stimulation.

Authors:  I Wessler; A Klein; D Pohan; J Maclagan; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

7.  Subtype-selective blockade of cardiac muscarinic receptors inhibits vagal chronotropic responses in cats.

Authors:  Oleg E Osadchii
Journal:  Pflugers Arch       Date:  2007-09-25       Impact factor: 3.657

8.  Muscarinic receptor subtypes in equine tracheal smooth muscle.

Authors:  M Yu; N E Robinson; Z Wang; F J Derksen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

9.  Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines.

Authors:  M S Reid; S Nishino; M Tafti; J M Siegel; W C Dement; E Mignot
Journal:  Exp Neurol       Date:  1998-05       Impact factor: 5.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.